» Articles » PMID: 33163654

Volatile Compounds of Black Cumin ( L.) Seeds Cultivated in Bangladesh and India

Overview
Journal Heliyon
Specialty Social Sciences
Date 2020 Nov 9
PMID 33163654
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The compositional analysis of volatile compounds of L. seeds obtained from India and Bangladesh was carried out in this study. Apart from the proportion of volatile compounds, the chemical composition of seeds from both sources were similar. The major volatile compounds in Bangladesh seeds were -cymene (36.35%), thymoquinone (29.77%), α-thujene (12.40%), carvacrol (2.85%), β-pinene (2.41%), limonene (1.64%), methyl linoleate (1.33%) and sabinene (1.18%), contribution of these is 87.93% of the total volatile oil. On the other hand, the major volatile compounds in Indian seeds were -cymene (41.80%), α-thujene (13.93%), thymoquinone (10.27%), methyl linoleate (4.02%), carvacrol (3.65%), β-pinene (2.96%), -limonene (2.11%), 4,5-epoxy-1-isopropyl-4- methyl-1-cyclohexene (1.80%), sabinene (1.50%) and 4-terpineol (1.22%); contribution of these were 83.24% of the total volatile oil. In both seeds, -cymene, thymoquinone, and α-thujene were the major components. Importantly, seeds of Bangladesh contained almost 3-fold thymoquinone compared to Indian seeds. In conclusion, the seeds from Bangladesh contain a higher amount of terpene ketones (29.86%) represented by thymoquinone in comparison to Indian seeds (10.61%); on the other hand, Indian seeds contained a higher amount of terpene hydrocarbons (63.18%) mainly -cymene, compared to Bangladesh seeds (54.53%). This is the first study to report detailed compositional analysis and comparison of L. seeds from Bangladesh and India.

Citing Articles

Effects of on disease activity, T lymphocytes and inflammatory cytokine profiles in pediatric systemic lupus erythematosus: A randomized controlled trial.

Barlianto W, Wulandari D, Sari T, Rachmaningrum R, Asasain R Narra J. 2025; 4(3):e1063.

PMID: 39816053 PMC: 11731933. DOI: 10.52225/narra.v4i3.1063.


Effect of ozonation on the phytochemicals of black seed oil and its anti-microbial, anti-oxidant, anti-inflammatory, and anti-neoplastic activities in vitro.

Al-Rajhi A, Abdelghany T, Almuhayawi M, Alruhaili M, Saddiq A, Baghdadi A Sci Rep. 2024; 14(1):30445.

PMID: 39663384 PMC: 11634964. DOI: 10.1038/s41598-024-81157-9.


A Comprehensive Review of Moroccan Medicinal Plants for Diabetes Management.

Boutaj H Diseases. 2024; 12(10).

PMID: 39452489 PMC: 11507334. DOI: 10.3390/diseases12100246.


Phytochemical Analysis and Anti-Biofilm Potential That Cause Dental Caries from Black Cumin Seeds ( Linn.).

Kurnia D, Padilah R, Apriyanti E, Dharsono H Drug Des Devel Ther. 2024; 18:1917-1932.

PMID: 38828022 PMC: 11144408. DOI: 10.2147/DDDT.S454217.


Insights into the antioxidant, anti-inflammatory and anti-microbial potential of Nigella sativa essential oil against oral pathogens.

Bhavikatti S, Zainuddin S, Ramli R, Nadaf S, Dandge P, Khalate M Sci Rep. 2024; 14(1):11878.

PMID: 38789533 PMC: 11126586. DOI: 10.1038/s41598-024-62915-1.


References
1.
Hassanien M, Assiri A, Alzohairy A, Oraby H . Health-promoting value and food applications of black cumin essential oil: an overview. J Food Sci Technol. 2015; 52(10):6136-42. PMC: 4573164. DOI: 10.1007/s13197-015-1785-4. View

2.
Botnick I, Xue W, Bar E, Ibdah M, Schwartz A, Joel D . Distribution of primary and specialized metabolites in Nigella sativa seeds, a spice with vast traditional and historical uses. Molecules. 2012; 17(9):10159-77. PMC: 6268483. DOI: 10.3390/molecules170910159. View

3.
Chaieb K, Kouidhi B, Jrah H, Mahdouani K, Bakhrouf A . Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement Altern Med. 2011; 11:29. PMC: 3095572. DOI: 10.1186/1472-6882-11-29. View

4.
Velagapudi R, El-Bakoush A, Lepiarz I, Ogunrinade F, Olajide O . AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia. Mol Cell Biochem. 2017; 435(1-2):149-162. PMC: 5632349. DOI: 10.1007/s11010-017-3064-3. View

5.
Mostofa A, Hossain M, Basak D, Sayeed M . Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies. Front Pharmacol. 2017; 8:295. PMC: 5466966. DOI: 10.3389/fphar.2017.00295. View